Both in Pharmaceuticals
Travere Therapeutics vs Erasca
Over the past year TVTX returned +51.7% and ERAS returned +505.9%; their daily moves had a correlation of 0.10.
TVTX +51.7% ERAS +505.9%Growth of $1, one year, split-adjusted
| Metric | TVTX | ERAS |
|---|---|---|
| Price | $52.40 | $14.42 |
| Market cap | $4.94B | $5.04B |
| Today | +6.04% | −1.50% |
| 1 month | −6.4% | +0.8% |
| 6 months | +17.1% | +32.3% |
| Year to date | +37.1% | +287.6% |
| 1 year | +51.7% | +505.9% |
| Revenue growth (YoY) | +36.2% | — |
| Gross margin | 98.7% | — |
| Net margin | −23.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.6× | — |
| Net cash | -$131.7M | $268.7M |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 59.6% |
| Short % of float | 12.1% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).